References
- Alammehrjerdi, Z., Ezard, N., & Dolan, K. (2018). Methamphetamine dependence in methadone treatment services in Iran: The first literature review of a new health concern. Asian Journal of Psychiatry, 31, 49–55. https://doi.org/10.1016/j.ajp.2018.01.001
- Ali, N., Aziz, S. A., Nordin, S., Mi, N. C., Abdullah, N., Paranthaman, V., Mahmud, M., Yee, A., & Danaee, M. (2017). Evaluation of methadone treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS). Substance Use and Misuse, 53(2), 239–248. https://doi.org/10.1080/10826084.2017.1385630
- Baharom, N., Hassan, M. R., Ali, N., & Shah, A. (2012). Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia. Substance Abuse Treatment, Prevention, and Policy, 7(1), 32. https://doi.org/10.1186/1747-597X-7-32
- Bao, Y. P., Liu, Z. M., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. American Journal of Drug and Alcohol Abuse, 35(1), 28–33. https://doi.org/10.1080/00952990802342899
- Best, D., Gossop, M., Stewart, D., Marsden, J., Lehmann, P., & Strang, J. (1999). Continued heroin use during methadone treatment: Relationship between frequency of use and reasons reported for heroin use. Drug and Alcohol Dependence, 53(3), 191–195. https://doi.org/10.1016/S0376-8716(98)00132-X
- Chawarski, M. C., Vicknasingam, B., Mazlan, M., & Schottenfeld, R. S. (2012). Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia. Drug and Alcohol Dependence, 124(1–2), 177–180. https://doi.org/10.1016/j.drugalcdep.2011.12.024
- Courtney, K. E., & Ray, L. A. (2014). Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence, 143, 11–21. https://doi.org/10.1016/j.drugalcdep.2014.08.003
- Degenhardt, L., Mathers, B., Guarinieri, M., Panda, S., Phillips, B., Strathdee, S. A., Tyndall, M., Wiessing, L., Wodak, A., & Howard, J., & the Reference Group to the United Nations on HIV and injecting drug use. (2010). Meth/amphetamine use and associated HIV: Implications for global policy and public health. International Journal of Drug Policy, 21(5), 347–358. https://doi.org/10.1016/j.drugpo.2009.11.007
- Donny, E. C., Brasser, S. M., Bigelow, G. E., Stitzer, M. L., & Walsh, S. L. (2005). Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction, 100(10), 1496–1509. https://doi.org/10.1111/add.2005.100.issue-10
- Ellinwood, E. H., Jr., Eibergen, R. D., & Kilbey, M. M. (1976). Stimulants: Interaction with clinically relevant drugs. Annals of the New York Academic of Sciences, 281(1), 393–408. https://doi.org/10.1111/j.1749-6632.1976.tb27948.x
- Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018). Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug and Alcohol Dependence, 193, 14–20. https://doi.org/10.1016/j.drugalcdep.2018.08.029
- Faggiano, F., Taglianti, F. V., Versino, E., & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews, (Issue 3). Art. No: CD002208. https://doi.org/10.1002/14651858.CD002208
- Fei, J. T. B., Yee, A., Habil, M. H. B., & Danaee, M. (2016). Effectiveness of methadone maintenance therapy and improvement in quality of life following a decade of implementation. Journal of Substance Abuse Treatment, 69, 50–56. https://doi.org/10.1016/j.jsat.2016.07.006
- Jasinski, D. R., & Preston, K. L. (1986). Evaluation of mixtures of morphine and d-Amphetamine for subjective and physiological effects. Drug and Alcohol Dependence, 17(1), 1–13. https://doi.org/10.1016/0376-8716(86)90031-1
- Khazaee-Pool, M., Moeeni, M., Ponnet, K., Fallahi, A., Jahangiri, L., & Pashaei, T. (2018). Perceived barriers to methadone maintenance treatment among Iranian opioid users. International Journal for Equity in Health, 17(75), 1–10. https://doi.org/10.1186/s12939-018-0787-z
- Liu, Y., Li, L., Zhang, L., Shen, W., Xu, H., Wang, G., Lu, W., & Zhou, W. (2013). Assessment of attitude towards methadone maintenance treatment between heroin users at a compulsory detoxification centre and methadone maintenance clinic in Ningbo, china. Substance Abuse Treatment, Prevention, and Policy, 8(29), 1–8. https://doi.org/10.1186/1747-597X-8-29
- Malaysian Aids Council. (2019). http://www.mac.org.my/v3/wp-content/uploads/2019/03/HIV-Overview_2017_Media_Brochure_A4_24092018-Print.pdf
- Massah, O., & Moradi, A. (2018). The prevalence of methamphetamine dependence among Iranian women in methadone maintenance therapy in Tehran, Iran. Iran Journal of Psychiatry, 13(1), 10–14.
- Mouly, S., Bloch, V., Peoc’h, K., Houze, P., Labat, L., Ksouda, K., Simoneau, G., Decleves, X., Bergmann, J. F., Scherrmann, J. M., Laplanche, J. L., Lepine, J. P., & Vorspan, F. (2014). Methadone dose in heroin-dependent patients: Role of clinical factors, comedications, genetic polymorphisms and enzyme activity. British Journal of Clinical Pharmacology, 79(6), 967–977. https://doi.org/10.1111/bcp.12576
- National Drug Report. (2018). National Anti-Drug Agency (NADA). https://www.adk.gov.my/orang-awam/statistik-dadah/
- Radfar, S. R., Cousins, S. J., Shariatirad, S., Noroozi, A., & Richard, A. (2016). Methamphetamine use among patients undergoing methadone maintenance treatment in Iran; a threat for human reduction and treatment strategies: A qualitative study. International Journal of High Risk Behaviors & Addiction, 5(4), e30327. https://doi.org/10.5812/ijhrba.30327
- Reid, G., Kamarulzaman, A., & Sran, S. K. (2007). Malaysia and harm reduction: The challenges and responses. International Journal of Drug Policy, 18(2), 136–140. https://doi.org/10.1016/j.drugpo.2006.12.015
- Shariatirad, S., Maarefvand, M., & Ekhtiari, H. (2013). Methamphetamine use and methadone maintenance treatment: An emerging problem in the drug addiction treatment network in Iran. International Journal of Drug Policy, 24(6), e115–e116. https://doi.org/10.1016/j.drugpo.2013.05.003
- Singh, D., Mamat, R. B., Narayanan, S., & Vicknasingam, B. (2019). Prevalence of Amphetamine-Type Stimulants (ATS) use among clients in primary and private Methadone Maintenance Treatment (MMT) program in Kuantan, Malaysia. Journal of Substance Use, 24(4), 1–6. https://doi.org/10.1080/14659891.2019.1642409
- Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial. JAMA, 281(11), 1000–1005. https://doi.org/10.1001/jama.281.11.1000
- Vicknasingam, B., Dazali, M. N. M., Singh, D., Schottenfeld, R. S., & Chawarski, M. C. (2015). Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients. Drug and Alcohol Dependence, 152, 164–169. https://doi.org/10.1016/j.drugalcdep.2015.04.007
- Wang, R., Ding, Y., Bai, H., Duan, S., Ye, R., Yang, Y., Wang, J., Tang, R., Gao, M., & He, N. (2015). Illicit heroin and methamphetamine use among methadone maintenance treatment patients in Dehong prefecture of Yunnan Province, China. PloS One, 10(7), e0133431. https://doi.org/10.1371/journal.pone.0133431
- Wegman, M. P., Altice, F. L., Kaur, S., Rajandaran, V., Osornprasop, S., Wilson, D., Wilson, D. W., & Kamarulzaman, A. (2017). Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: A two-arm, prospective observational study. Lancet Global Health, 5(2), e198–e207. https://doi.org/10.1016/S2214-109X(16)30303-5